The adjuvant effects of rapamycin, metformin and aspirin on the T-cell immunological memory induced by tuberculosis subunit vaccine
preprint
OA: closed
CC-BY-NC-SA-4.0
Abstract
The formation of long-lived T-cell immunological memory is a critical goal of vaccines against intracellular pathogens like Mycobacterium tuberculosis ( M. tuberculosis ). In this study, to verify the adjuvant effect of the metabolic regulator on T-cell memory induced by the tuberculosis subunit vaccine, we treated the mice with rapamycin, metformin and aspirin during the course of vaccination and then monitored the vaccine-specific long-term memory T cell responses and protective ability against mycobacterial organism. Compared with the mice that received the vaccine alone, rapamycin and metformin treatments enhanced the vaccine-specific long-term T-cell memory responses, and the potentiating effect of rapamycin is better than metformin. In particular, we found that a long duration of low-dose rapamycin treatment promoted the development of more T CM like cells and enhanced the vaccine’s long-term protective efficacy, which resulted in a better decline of 0.89-log10 CFU of mycobacterial organisms in lungs. These findings might have important implications for developing new vaccination strategies for the TB subunit vaccine.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-NC-SA-4.0